Clinical Trials Logo

Clinical Trial Summary

To identify biochemical, clinical, or genetic biomarkers that may predict responsiveness to iNO in neonates with PPHN/HRF. The primary outcome will be identification of any biomarker(s) associated with response to iNO therapy. We will evaluate related biomarkers at various time-points during disease progression and in response to therapy, including single nucleotide polymorphisms in the cyclic adenosine monophosphate/cyclic guanosine monophosphate-Phosphodiesterase (PDE) pathway, indicators of metabolic dysregulation and inflammation, as well as biochemical markers of heart strain. We will perform targeted neonatal echocardiograms to evaluate severity of PPHN and heart function both as an added clinical biomarker and to follow disease progression.


Clinical Trial Description

A single-center, prospective observational cohort study evaluating potential biochemical, clinical, and/or genetic biomarkers in neonates admitted with a diagnosis of PPHN that may predict iNO response. Thus, it is important to collect data prior to the initiation of iNO to be able to identify biomarkers that can predict response. For patients who meet the screening criteria and when consent is not attainable prior to initiation of the potential life-saving iNO therapy, then samples will be obtained with deferred written informed parental consent obtained within the first 4 hours after enrollment. These patients will have one sample of blood, urine, and tracheal aspirate (if available) collected. If the patient meets the inclusion and exclusion criteria, the patient will be recruited for study participation. To ensure no delay in care or in the initiation of the only FDA-approved vasodilator for this population, iNO, a deferred written informed parental consent is requested to allow for the collection of blood, urine, tracheal aspirate specimens (if available) prior to the initiation of iNO. Only one sample of blood and tracheal aspirate specimens will be collected prior to the deferred consent. Samples are often collected during the routine collections that are obtain from patients who are critically ill such as in our study participants, therefore, no additional discomfort will be expected from this study. Urine collection will be from cotton ball collection that would normally be discarded and is noninvasive. All data and biospecimens obtained from eligible infants whose parent(s) decline consent or do not qualify for the study will be discarded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06043635
Study type Observational
Source Nationwide Children's Hospital
Contact
Status Withdrawn
Phase
Start date July 15, 2021
Completion date December 1, 2022

See also
  Status Clinical Trial Phase
Terminated NCT04344561 - Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation N/A
Completed NCT04380727 - Almitrine and COVID-19 Related Hypoxemia
Completed NCT04385823 - Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure
Recruiting NCT04415060 - SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival Phase 3
Terminated NCT04433546 - Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). Phase 2
Not yet recruiting NCT05689216 - Timed Awake Prone and Repositioning for Patients With Covid-19-induced Hypoxic Respiratory Failure. N/A
Completed NCT02184208 - Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System. N/A
Completed NCT04648657 - Lung Ultrasound, PEEP and Overdistension (LUPO)
Recruiting NCT06140056 - Two Modes of Mechanical Ventilation for Intensive Care Patients With Low Blood Oxygen Due to Breathing Difficulties N/A
Terminated NCT01069861 - Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) Phase 2
Recruiting NCT03835741 - Automated Adjustment of Oxygen on Patient With Acute COPD Exacerbation - FreeO2 HypHop N/A
Completed NCT03082105 - Snow Physical Properties and Human Ventilatory Response N/A
Recruiting NCT04049240 - Effect of HFNO on Spontaneous Ventilation in Obese Patients During Analgo-sedation for Vitrectomy N/A
Not yet recruiting NCT06336265 - Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High-flow Nasal Cannula Oxygen Therapy